FDA Inspection 1330750 — UCB Biosciences Inc.
The FDA completed an inspection of UCB Biosciences Inc. on Jul 29, 2026 in Smyrna, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 29, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Smyrna, GA (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)